Business

Global Canine Influenza Vaccine Market Size, Innovations Driving Market Evolution 2024-2032

Mr Accuracyreports has published a new research report titled “

Global Canine Influenza Vaccine Market Size By Type (Powder, Liquid), By Application (Home, Pet Clinic), By Geographic Scope And Forecast

” in its research database. Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology, and Graphs –

https://www.mraccuracyreports.com/marketreports/5/857138/Canine-Influenza-Vaccine-Market

https://www.mraccuracyreports.com/request/download/5/857138/Canine-Influenza-Vaccine-Market

Canine Influenza Vaccine Market Size And Forecast

Canine Influenza Vaccine Market size was valued at USD 1,031.27 Million in 2022 and is projected to reach USD 1,663.64 Million by 2030, growing at a CAGR of 5.26% from 2024 to 2030.

Canine influenza vaccines is also known as canine flu. This flu is caused by various strains of influenza A, most of which are equine flu H3N8. It can be spread through vapor sprays or droplets from sneezing, coughing and barking. This can happen when a healthy dog ​​approaches a sick dog. Sometimes it is spread by the action of people or objects that have recently come into contact with a sick dog. The virus can also be spread through contaminated items such as food and water bowls, collars, collars, toys, bedding, and nose-to-nose contact between dogs. Canine influenza vaccines is a serious illness, not a respiratory illness. The canine flu vaccine is the best defense against the flu. In June 2009, the first Canine influenza vaccines vaccine became available.

Global Canine Influenza Vaccine Market Definition

The canine flu vaccine is a vaccine designed to protect dogs from contracting serious respiratory illnesses caused by the canine flu virus (CIV). This vaccine is designed to stimulate the dog’s immune system to recognize and eliminate certain strains of CIV. Through vaccination, it will help reduce the incidence and severity of the disease and stop the spread of the disease in the canine population. The vaccine works by stimulating the dog’s immune system to produce antibodies against CIV, making them more resistant to the virus and reducing the risk of complications.

What’s inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Canine Influenza Vaccine Market Overview

Canine flu is a disease that has spread worldwide and has now become a health concern for all dog lovers. Canine flu spreads quickly and if treatment is delayed, it can cause serious illness in dogs, such as pneumonia. For example; According to the American Veterinary Medical Association (AVMA); Los Angeles County has reported approximately 800 confirmed and related CIV H3N2 cases and 7 deaths from the virus.

In addition, the advancement of technology in this field also contributes to the growth of the sector. For example; Luis Martinez-Sobrido of the Department of Microbiology and Immunology has developed two vaccines against the H3N8 canine flu, which is now common in dogs in the United States, as announced on January 28, 2017.

The H3N8 vaccine is made using a genetically modified virus. Vaccination for dogs is a safe and effective way to protect dogs against infectious diseases. The Canine influenza vaccines vaccine is given to pet sitters and kennels, kennels, or other high-traffic areas where dogs can mingle with other dogs. Therefore, awareness of vaccination has increased in the development industry.

Global Canine Influenza Vaccine Market Segmentation Analysis

The Global Canine Influenza Vaccine Market is segmented on the basis of Type, Application, And Geography.

Canine Influenza Vaccine Market, By Type

  • Liquid
  • Powder

Based on Type, the market is segmented into Liquid, and Powder. The Powder segment is also expected to witness significant growth in the market during the forecast period. Powdered vaccines can be taken orally and are easier, especially for dogs that are resistant to injections or nasal sprays. This can be especially helpful for dog owners or veterinarians who have trouble vaccinating their dogs. Powder vaccines generally have better stability and longer shelf life than liquid vaccines. They may need less storage, such as refrigeration, which can be easily loaded, distributed and stored. The availability of a canine flu vaccine can facilitate mass vaccination, especially where large numbers of dogs need to be vaccinated quickly.Ease of administration and needle-free injection capability can make the procedure simple and effective leading to better market growth in the forecasted period.

Canine Influenza Vaccine Market, By Application

  • Home
  • Pet Clinic
  • Others

Based on Application, the market is segmented into Home, Pet Clinic, and Others. Canine influenza vaccines are usually available from veterinary clinics and animal hospitals. These facilities are equipped with the necessary vaccines and treatments for dogs.Although some oral vaccines or vaccines, such as flu shots, can be given at home, flu shots are usually given by injection and require a specialist to administer. Canine influenza vaccines vaccination is recommended by a licensed veterinarian to ensure dosage and control. Hence, the pet clinics are expected to driv ethe market growth in the forecasted period.

Canine Influenza Vaccine Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

On the basis of Regional Analysis, The Global Canine Influenza Vaccine Market is classified into North America, Europe, Middle East and Africa, Latin America. North America is expected to lead the global flu vaccine market due to disease outbreak in the region. For example; According to Fox News, an estimated 800 dogs contracted the flu between July 2021 and October 2021 in Los Angeles. In addition, the growth of animal husbandry causes the economy to grow, because the increase in the number of animals will increase the use of vaccines. For example, according to the American Pet Products Association (APPA), America adopted 1.9 million pets in 2020. Also, new developments in North America will provide an opportunity for research into canine flu vaccines, which is expected to increase the growth of flu vaccines worldwide.

Asia Pacific is expected to be the largest canine flu region worldwide due to the emergence of new flu viruses. For example; According to the Canine Journal vaccine, a new virus (H1N1) was detected in dogs in China in June 2018. In addition, innovations in North America will provide opportunities for canine flu vaccine research, which is expected to support the growth of flu vaccines globally. The Asia-Pacific region is expected to be the largest Canine influenza vaccines region in the world due to the emergence of new influenza viruses. For example; A new virus (H1N1) was found in dogs in China in June 2018, the Canine Journal Vaccine reported.

Key Players

The “Global Canine Influenza Vaccine Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Zoetis Inc., Merck Animal Health, GlaxoSmithKline Plc., Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Pfizer Inc., Boehringer Ingelheim International GmbH, Sanofi, Abbott Laboratories, F. Hoffmann-La Roche Ltd.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In November 2018, Merck and Zoetis collaborate to develop new canine flu vaccine. Both companies are accelerating and rolling out H3N2 vaccines just in time for flu season. Merck announced that it has received USDA approval to market its H3N2 flu vaccine, just one week after Zoetis received the same USDA-approved approval for its vaccine.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Canine Influenza Vaccine Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in Global Canine Influenza Vaccine Market gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Report Attributes Details
Study Period

2019-2030

Base Year

2022

Forecast Period

2024-2030

Historical Period

2019-2021

UNIT

Value (USD Million)

Key Companies Profiled

Zoetis Inc., Merck Animal Health, GlaxoSmithKline Plc., Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Pfizer Inc

Segments Covered
  • By Type
  • By Application
  • By Geography
Customization scope

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports

<a href=”https://www.verif